Abstract:Schwann cell differentiation and myelination in the PNS are the result of fine-tuning of positive and negative transcriptional regulators. As myelination starts, negative regulators are downregulated, whereas positive ones are upregulated. Fully differentiated Schwann cells maintain an extraordinary plasticity and can transdifferentiate into "repair" Schwann cells after nerve injury. Reactivation of negative regulators of myelination is essential to generate repair Schwann cells. Negative regulators have also been implicated in demyelinating neuropathies, although their role in disease remains elusive. Here, we used a mouse model of Charcot-Marie-Tooth neuropathy type 1B (CMT1B), the P0S63del mouse characterized by ER stress and the activation of the unfolded protein response, to show that adult Schwann cells are in a partial differentiation state because they overexpress transcription factors that are normally expressed only before myelination. We provide evidence that two of these factors, Sox2 and Id2, act as negative regulators of myelination in vivo However, their sustained expression in neuropathy is protective because ablation of Sox2 or/and Id2 from S63del mice of both sexes results in worsening of the dysmyelinating phenotype. This is accompanied by increased levels of mutant P0 expression and exacerbation of ER stress, suggesting that limited differentiation may represent a novel adaptive mechanism through which Schwann cells counter the toxic effect of a mutant terminal differentiation protein.SIGNIFICANCE STATEMENT In many neuropathies, Schwann cells express high levels of early differentiation genes, but the significance of these altered expression remained unclear. Because many of these factors may act as negative regulators of myelination, it was suggested that their misexpression could contribute to dysmyelination. Here, we show that the transcription factors Sox2 and Id2 act as negative regulators of myelination in vivo, but that their sustained expression in Charcot-Marie-Tooth type 1B (CMT1B) represents an adaptive response activated by the Schwann cells to reduce mutant protein toxicity and prevent demyelination.

Molecular Mechanisms Involved in Schwann Cell Plasticity

Mechanisms of Schwann cell plasticity involved in peripheral nerve repair after injury

Repair Schwann cell update: Adaptive reprogramming, EMT, and stemness in regenerating nerves

Schwann Cells as Orchestrators of Nerve Repair: Implications for Tissue Regeneration and Pathologies

The Success and Failure of the Schwann Cell Response to Nerve Injury

Influence of Mechanical Stimuli on Schwann Cell Biology

Promoting peripheral myelin repair

The repair Schwann cell and its function in regenerating nerves

Emerging Role of Schwann Cells in Neuropathic Pain: Receptors, Glial Mediators and Myelination.

Schwann Cell-Like Cells Derived from Human Amniotic Mesenchymal Stem Cells Promote Peripheral Nerve Regeneration Through a MicroRNA-214/c-Jun Pathway

The Role of Schwann Cell-Axon Interaction in Peripheral Nerve Regeneration

The phenotypic changes of Schwann cells promote the functional repair of nerve injury

Molecular mechanisms of cellular interactions in peripheral nerve regeneration

Schwann Cell-Like Cells: Origin and Usability for Repair and Regeneration of the Peripheral and Central Nervous System

Schwann cell development, maturation and regeneration: a focus on classic and emerging intracellular signaling pathways

Advances of Schwann cells in peripheral nerve regeneration: From mechanism to cell therapy

Review: Myelin clearance is critical for regeneration after peripheral nerve injury

Axonal Regeneration after Spinal Cord Injury: Molecular Mechanisms, Regulatory Pathways, and Novel Strategies

Effects of ECM proteins (laminin, fibronectin, and type IV collagen) on the biological behavior of Schwann cells and their roles in the process of remyelination after peripheral nerve injury

Sustained Expression of Negative Regulators of Myelination Protects Schwann Cells from Dysmyelination in a Charcot-Marie-Tooth 1B Mouse Model

Changes in the Coding and Non-coding Transcriptome and DNA Methylome that Define the Schwann Cell Repair Phenotype after Nerve Injury